Book · Julian R. Sterling
A Practitioner's Guide for Hospitals and Health Centers: Eligibility and Registration, the Patient Definition, the GPO Prohibition, Medicaid Duplicate Discounts, Contract Pharmacy and TPAs, Split Billing, Measuring 340B Savings, Manufacturer Restrictions and the Rebate Model, Self-Audits, HRSA Audits and the Program Model
A hospital closes its 340B year with potential gross savings of $10,310,966.70. A manufacturer restriction on one contract pharmacy line takes $809,600.00, the Medicaid carve-in passes $956,399.00 to the state, and contract pharmacy dispensing and TPA fees take $99,594.00 and $46,271.60. Net savings are $8,399,102.10, 81.46 percent of the potential. Measured against the GPO price instead of WAC, gross savings read $7,782,234.50 instead of $9,501,366.70. Then the self-audit finds 4 noncompliant claims out of 40, and an extrapolated exposure of $255,317.81 against a policy threshold of $25,000.00. Which of those figures would the board, the auditors, a manufacturer and HRSA ask you to prove, and how?
The 340B Program Handbook is a working guide to the federal drug pricing program as a hospital or health center runs it: how eligibility is tested and kept in OPAIS, including off-campus sites and the cost report line, how the patient definition is applied to a prescription, what the GPO prohibition requires, how a neutral inventory and an accumulator replenish mixed-use areas, how carve-in and carve-out keep Medicaid duplicate discounts out, how contract pharmacies and a TPA are paid and controlled, how 340B savings are measured against WAC and against the GPO price and bridged to net savings, what manufacturer restrictions and a rebate model cost, how Medicare pays for 340B drugs, and how a self-audit, an HRSA audit, a corrective action plan and a self-disclosure are run.
What is inside:
Written for 340B program managers and coordinators of hospitals and health centers; directors of pharmacy; chief financial officers and controllers who measure the savings; internal auditors and compliance officers; the consultants and TPAs who serve them; and counsel preparing an HRSA audit. The hospitals, pharmacies and people are fictional, no real manufacturer, drug, wholesaler, group purchasing organization or TPA is named, and every figure of the case is a teaching assumption, not a market figure. The statute, HRSA's guidance and notices, the CMS rules and the court decisions are described in principle, as read on stated dates. This book is for education only. It is not legal, regulatory, reimbursement or accounting advice.
The workbook behind every figure of the book. Inputs in blue, formulas in black, and a Controls tab that counts the exceptions. No sign-up.
Appendix A, chapters 1 to 15
Thirteen tabs: Sites, Products, Dispensations, Accounts and Accumulator, Medicaid, Savings and Bridge, Contract Pharmacies, Restrictions, Rebate Scenario, Self-Audit, Health Center, Sensitivities and Controls. Registers on the left, results computed from them, no circular reference, every division guarded.
Download 340B_Program_Workbook.xlsx61 KBStart with 00_START_HERE.md, which explains the tabs and the order to read them in.
Want to test your own lines first? The free 340B savings calculator takes units, the 340B price, the GPO price and WAC by product line, the Medicaid share, the contract pharmacy reimbursement and fees, a restriction and a rebate float, and returns gross savings against WAC and GPO, the net by channel, the net benefit per claim and the total.
Related titles. The full list is on the author page.